Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.4K
Cancer Survival Analysis01:21

Cancer Survival Analysis

311
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
311

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Drug-induced cell viability prediction from LINCS-L1000 through WRFEN-XGBoost algorithm.

BMC bioinformatics·2021
Same author

Deconvolution of heterogeneous tumor samples using partial reference signals.

PLoS computational biology·2020
Same author

Iterative sure independent ranking and screening for drug response prediction.

BMC medical informatics and decision making·2020
Same author

A quantile regression forest based method to predict drug response and assess prediction reliability.

PloS one·2018
Same author

The regulatory activities of plant microRNAs: a more dynamic perspective.

Plant physiology·2011
Same author

Complete genome sequence of the type strain Pseudomonas stutzeri CGMCC 1.1803.

Journal of bacteriology·2011
Same journal

Another 10 years of PLOS Computational Biology: A data-driven reflection on trends in genomics research.

PLoS computational biology·2026
Same journal

Mobility data resolution needed to inform predictive models of spatial epidemic spread from mobile phone data.

PLoS computational biology·2026
Same journal

DeepMethylation: A deep learning framework for tissue-specific DNA methylation prediction and functional variant annotation.

PLoS computational biology·2026
Same journal

Redefining and estimating the early-phase reproduction ratio for epidemic outbreaks in spatially structured populations.

PLoS computational biology·2026
Same journal

Optimized phenotype definitions boost GWAS power.

PLoS computational biology·2026
Same journal

Detection, communication, and individual identification with deep audio embeddings: A case study with North Atlantic right whales.

PLoS computational biology·2026
查看所有相关文章

相关实验视频

Updated: May 16, 2025

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

918

抗癌药物反应预测整合了基于多omics路径的差异特征和多种深度学习技术.

Yang Wu1,2, Ming Chen1,2, Yufang Qin1,2

  • 1College of Information Technology, Shanghai Ocean University, Shanghai, China.

PLoS computational biology
|March 31, 2025
PubMed
概括
此摘要是机器生成的。

这项研究介绍了PASO,这是一个深度学习模型,用于使用omics数据和药物结构来预测个体癌症药物敏感性. 帕索实现了高精度,识别了特定癌症的敏感药物类别,并帮助精准医学.

更多相关视频

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.2K
Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
07:47

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies

Published on: September 15, 2023

1.4K

相关实验视频

Last Updated: May 16, 2025

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

918
Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.2K
Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
07:47

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies

Published on: September 15, 2023

1.4K

科学领域:

  • 计算生物学是一种计算生物学.
  • 基因组学就是基因组学.
  • 药理学 药理学是指药理学的学科.

背景情况:

  • 对癌症药物敏感性的个性化预测对于精准医学至关重要.
  • 当前的预测方法在准确预测患者的反应和理解个体间的变化方面面临挑战.
  • 奥米克斯数据和药物化学结构为预测建模提供了丰富的信息.

研究的目的:

  • 开发一种深度学习模型 (PASO) 来准确预测细胞系中的抗癌药物敏感性.
  • 将多样化的OMIC数据与药物分子结构集成,以提高预测能力.
  • 确定影响药物反应的关键生物途径和药物特征.

主要方法:

  • 使用了omics数据 (基因表达,突变,拷贝数变异) 和药物的SMILES表示作为输入.
  • 开发了一个深度学习架构,集成了多级卷积网络,变压器编码器和注意力机制.
  • 采用统计方法来导出基于途径的细胞系特征.

主要成果:

  • 与现有方法相比,PASO模型在预测抗癌药物敏感性方面表现出卓越的准确性.
  • 确定了特定的药物类别 (PARP和拓酶I抑制剂),对小细胞肺癌 (SCLC) 具有高度敏感性.
  • 该模型成功地突出了相关的生物途径和关键药物结构部件.

结论:

  • 帕索模型显示出作为支持个性化癌症治疗策略的工具的巨大潜力.
  • 该方法为在药物敏感性预测中整合多模式数据提供了一个强大的框架.
  • 开发的方法是公开的,以促进进一步的研究和临床应用.